The warning applies to all prescription and over-the-counter versions of ranitidine, best known by the brand name Zantac. Many makers of ranitidine drugs already removed their products from the market, including Zantac-manufacturer Sanofi. Since then, hundreds of batches of ranitidine drugs have been recalled. ALTERNATIVES TO CANCER-LINKED ZANTAC FOR HEARTBURN Zantac and its active ingredient, ranitidine are members of a class of drugs called H2 blockers. Although the FDA is now investigating heartburn drugs broadly, there have not yet been reports of NDMA linked to any of the other H2 blockers.

Source: Daily Mail April 01, 2020 18:43 UTC